nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acute myocardial infarction: facilitation and transport strategies
|
|
|
2003 |
92 |
6S1 |
p. 152-154 3 p. |
artikel |
2 |
Adjunct pharmacology in coronary intervention I
|
|
|
2003 |
92 |
6S1 |
p. 127-131 5 p. |
artikel |
3 |
Adjunct pharmacology in coronary intervention II
|
|
|
2003 |
92 |
6S1 |
p. 132-135 4 p. |
artikel |
4 |
Aortic intervention (abdominal and thoracic)
|
|
|
2003 |
92 |
6S1 |
p. 84-86 3 p. |
artikel |
5 |
Approaches to bifurcation intervention
|
|
|
2003 |
92 |
6S1 |
p. 62-65 4 p. |
artikel |
6 |
Basic science and experimental observations
|
|
|
2003 |
92 |
6S1 |
p. 222-227 6 p. |
artikel |
7 |
Clinical trials in acute myocardial infarction and acute coronary syndrome
|
|
|
2003 |
92 |
6S1 |
p. 69-72 4 p. |
artikel |
8 |
Detection and management of vulnerable plaque
|
|
|
2003 |
92 |
6S1 |
p. 5-8 4 p. |
artikel |
9 |
Developments in cardiac surgery
|
|
|
2003 |
92 |
6S1 |
p. 125-126 2 p. |
artikel |
10 |
Distal protection devices during saphenous vein graft intervention
|
|
|
2003 |
92 |
6S1 |
p. 32-35 4 p. |
artikel |
11 |
Drug-eluting stents 2-economics and cost effectiveness
|
|
|
2003 |
92 |
6S1 |
p. 25-27 3 p. |
artikel |
12 |
Drug-eluting stents 4-paclitaxel, everolimus, and other agents
|
|
|
2003 |
92 |
6S1 |
p. 59-61 3 p. |
artikel |
13 |
Drug-eluting stents 1— preclinical
|
|
|
2003 |
92 |
6S1 |
p. 21-24 4 p. |
artikel |
14 |
Drug-eluting stents 3-restenosis following stenting with drug-eluting stents
|
|
|
2003 |
92 |
6S1 |
p. 56-58 3 p. |
artikel |
15 |
Drug-eluting stents, 5-sirolimus stents and oral rapamycin
|
|
|
2003 |
92 |
6S1 |
p. 91-93 3 p. |
artikel |
16 |
Endovascular intervention
|
|
|
2003 |
92 |
6S1 |
p. 155-159 5 p. |
artikel |
17 |
Endovascular interventions-studies and strategies
|
|
|
2003 |
92 |
6S1 |
p. 81-83 3 p. |
artikel |
18 |
Genetic studies, cell therapy and angiogenesis II
|
|
|
2003 |
92 |
6S1 |
p. 104-108 5 p. |
artikel |
19 |
Interventional approaches to septal defects, valve disease, and hypertrophic cardiomyopathy
|
|
|
2003 |
92 |
6S1 |
p. 13-16 4 p. |
artikel |
20 |
Interventional approaches to septal defects, valve disease, and hypertrophic cardiomyopathy
|
|
|
2003 |
92 |
6S1 |
p. 160-165 6 p. |
artikel |
21 |
Intervention in acute myocardial infarction
|
|
|
2003 |
92 |
6S1 |
p. 1-4 4 p. |
artikel |
22 |
Intervention in acute myocardial infarction I
|
|
|
2003 |
92 |
6S1 |
p. 109-114 6 p. |
artikel |
23 |
Intervention in acute myocardial infarction II
|
|
|
2003 |
92 |
6S1 |
p. 115-120 6 p. |
artikel |
24 |
Intervention in complex lesions: chronic occlusions and diffuse disease
|
|
|
2003 |
92 |
6S1 |
p. 66-68 3 p. |
artikel |
25 |
Intervention in high-risk subgroups
|
|
|
2003 |
92 |
6S1 |
p. 136-140 5 p. |
artikel |
26 |
Intervention in high-risk subgroups II
|
|
|
2003 |
92 |
6S1 |
p. 141-145 5 p. |
artikel |
27 |
Intervention in high-risk subgroups (women, elderly, diabetes, chronic renal failure)
|
|
|
2003 |
92 |
6S1 |
p. 77-80 4 p. |
artikel |
28 |
Invasive and pharmacologic approaches in acute coronary syndromes
|
|
|
2003 |
92 |
6S1 |
p. 231-233 3 p. |
artikel |
29 |
Neurovascular intervention
|
|
|
2003 |
92 |
6S1 |
p. 121-124 4 p. |
artikel |
30 |
Neurovascular intervention-studies and strategies
|
|
|
2003 |
92 |
6S1 |
p. 49-52 4 p. |
artikel |
31 |
New atherectomy and thrombectomy devices and data
|
|
|
2003 |
92 |
6S1 |
p. 73-76 4 p. |
artikel |
32 |
New directions for atherectomy and thrombectomy devices
|
|
|
2003 |
92 |
6S1 |
p. 219-221 3 p. |
artikel |
33 |
New insights from imaging and physiologic lesion assessment
|
|
|
2003 |
92 |
6S1 |
p. 199-204 6 p. |
artikel |
34 |
New insights from imaging and physiologic lesion assessment
|
|
|
2003 |
92 |
6S1 |
p. 45-48 4 p. |
artikel |
35 |
Non-stent devices
|
|
|
2003 |
92 |
6S1 |
p. 166-171 6 p. |
artikel |
36 |
Novel anti-restenosis therapies
|
|
|
2003 |
92 |
6S1 |
p. 94-97 4 p. |
artikel |
37 |
Outcomes of unprotected left main intervention
|
|
|
2003 |
92 |
6S1 |
p. 28-31 4 p. |
artikel |
38 |
Pharmacotherapy in acute coronary syndromes and acute myocardial infarction
|
|
|
2003 |
92 |
6S1 |
p. 228-230 3 p. |
artikel |
39 |
Pharmacotherapy in acute coronary syndromes and myocardial infarction
|
|
|
2003 |
92 |
6S1 |
p. 40-44 5 p. |
artikel |
40 |
Pharmacotherapy in percutaneous coronary intervention
|
|
|
2003 |
92 |
6S1 |
p. 9-12 4 p. |
artikel |
41 |
Renal intervention with and without distal protection
|
|
|
2003 |
92 |
6S1 |
p. 53-55 3 p. |
artikel |
42 |
Studies with bare-metal stents I
|
|
|
2003 |
92 |
6S1 |
p. 205-211 7 p. |
artikel |
43 |
Studies with bare-metal stents II
|
|
|
2003 |
92 |
6S1 |
p. 212-218 7 p. |
artikel |
44 |
Studies with drug-eluting stents I
|
|
|
2003 |
92 |
6S1 |
p. 178-182 5 p. |
artikel |
45 |
Studies with drug-eluting stents II
|
|
|
2003 |
92 |
6S1 |
p. 183-188 6 p. |
artikel |
46 |
Thrombectomy and distal protection devices in acute myocardial infarction
|
|
|
2003 |
92 |
6S1 |
p. 189-193 5 p. |
artikel |
47 |
Thrombectomy and distal protection in acute myocardial infarction
|
|
|
2003 |
92 |
6S1 |
p. 36-39 4 p. |
artikel |
48 |
2003 transcatheter cardiovascular therapeutics
|
|
|
2003 |
92 |
6S1 |
p. 98-103 6 p. |
artikel |
49 |
Vascular access and closure
|
|
|
2003 |
92 |
6S1 |
p. 146-151 6 p. |
artikel |
50 |
Vascular access and closure
|
|
|
2003 |
92 |
6S1 |
p. 17-20 4 p. |
artikel |
51 |
Vascular brachytherapy applications
|
|
|
2003 |
92 |
6S1 |
p. 87-90 4 p. |
artikel |
52 |
Vascular brachytherapy applications
|
|
|
2003 |
92 |
6S1 |
p. 172-177 6 p. |
artikel |
53 |
Vulnerable plaque: science, detection, and therapy
|
|
|
2003 |
92 |
6S1 |
p. 194-198 5 p. |
artikel |